Skip to content

Study on the Correlation between Helicobacter Pylori Infection and Tongue Coating Microecology

Study on the Correlation between Helicobacter Pylori Infection and Tongue Coating Microecology

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100042497
Enrollment
Unknown
Registered
2021-01-22
Start date
2021-01-20
Completion date
Unknown
Last updated
2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacter pylori infection

Interventions

Non-infected group:no

Sponsors

Hubei Province Hospital of TCM
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged between 18-65 years; 2. Meet the diagnostic criteria for Helicobacter pylori infection or non- Helicobacter pylori infection; 3. PPI, H2RA and antibiotic treatments should be stopped two weeks before the 13C breath test or 14C breath test, and those who test positive for HP; 4. Patients who give informed consent and are willing to accept the trial.

Exclusion criteria

Exclusion criteria: 1. Patients with chronic atrophic gastritis with severe dysplasia, upper gastrointestinal bleeding, peptic ulcer and gastrointestinal tumor; 2. Organic diseases of the digestive system (such as chronic pancreatitis, liver cirrhosis, etc.), or other systemic diseases (such as hyperthyroidism, diabetes, chronic renal insufficiency, mental and neurological diseases, etc.); or other serious underlying diseases, Such as coronary heart disease, heart failure, liver and kidney failure; 3. Those who use drugs (antacids, H2RA, PPIs, antibiotics, etc.) that may affect the HP test results within 2 weeks; 4. Persons with severe allergies; 5. Women who are breastfeeding, pregnant or planning to become pregnant: 6. Persons who have serious bad habits such as smoking, alcohol or drugs; 7. Patients who need to take non-steroidal anti-inflammatory drugs for a long period of time cannot be ruled out for patients who interfere with other drugs; 8. Those who have poor compliance and difficulty in completing this experiment, which may affect the efficacy or safety judgment.

Design outcomes

Primary

MeasureTime frame
Flora density;Cell Apoptosis;Flora structure;

Countries

China

Contacts

Public ContactQiong Yang

Hubei University of Chinese Medicine

517222878@qq.com+86 13871461460

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026